LEIDEN, Netherlands (AP) — LEIDEN, Netherlands (AP) — ProQR Therapeutics NV (PRQR) on Thursday reported a loss of $10.1 million in its second quarter.

On a per-share basis, the Leiden, Netherlands-based company said it had a loss of 10 cents.

The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 14 cents per share.

The Dutch drugmaker posted revenue of $10.2 million in the period, also beating Street forecasts. Three analysts surveyed by Zacks expected $5.6 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PRQR at https://www.zacks.com/ap/PRQR